Reuters logo
BRIEF-Medicare advisory panel, in vote, expresses skepticism of brain-plaque imaging
January 30, 2013 / 7:56 PM / 5 years ago

BRIEF-Medicare advisory panel, in vote, expresses skepticism of brain-plaque imaging

Jan 30 (Reuters) - Eli Lilly and Co : * Medicare advisory panel, in vote, expresses skepticism brain-plaque imaging

can change health outcomes in patients with early cognitive problems * Three members of medical advisory panel vote “low” confidence there is

adequate evidence PET imaging of brain beta amyloid changes health outcomes * Five panel members vote low-to-intermediate confidence imaging technique can

affect patient outcomes * Three panel members vote intermediate confidence imaging technique can affect

patient outcomes * One member of medical advisory panel votes higher confidence

imaging technique can affect patient outcomes * Panel members reviewing imaging technique involving PET scans of Eli lilly’s

Amyvid imaging agent to detect brain plaque

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below